Flora Growth (FRA:7301) Debt-to-Equity : 1.25 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Flora Growth Debt-to-Equity?

Flora Growth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €2.76 Mil. Flora Growth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €2.01 Mil. Flora Growth's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €3.83 Mil. Flora Growth's debt to equity for the quarter that ended in Sep. 2024 was 1.25.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Flora Growth's Debt-to-Equity or its related term are showing as below:

FRA:7301' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.03 Med: 0.07 Max: 1.82
Current: 1.25

During the past 5 years, the highest Debt-to-Equity Ratio of Flora Growth was 1.82. The lowest was -1.03. And the median was 0.07.

FRA:7301's Debt-to-Equity is ranked worse than
89.95% of 826 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs FRA:7301: 1.25

Flora Growth Debt-to-Equity Historical Data

The historical data trend for Flora Growth's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Debt-to-Equity Chart

Flora Growth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-1.03

0.04

0.02

0.07

0.57

Flora Growth Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial													0.22	0.57	1.82	0.77	1.25

Competitive Comparison of Flora Growth's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Flora Growth's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Flora Growth's Debt-to-Equity falls into.

Flora Growth Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Flora Growth's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.503	+	0.864)	/	5.872
	=	0.57

Flora Growth's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.763	+	2.012)	/	3.829
	=	1.25

Flora Growth (FRA:7301) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Flora Growth Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Flora Growth's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Flora Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

FLGC:USA 7301:Germany

Address

3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132

Website

https://www.floragrowth.com

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Flora Growth Headlines

No Headlines